ls directly killing tumor cells, which has potential to act as a biomarker of immunotherapy efficacy MRA Established Investigator Award, 2017-2020 Umar Mahmood, Massachusetts General Hospital Development of YAP inhibitors to modulate regulatory T cell in melanoma: Plans to manipulate regulatory T cell func